Results 1 to 10 of about 4,105,290 (355)

Acknowledgement to Reviewers of Antibodies in 2018 [PDF]

Antibodies, 2019
Peer review is an essential part of the publication process, ensuring that Antibodies maintains high quality standards for its published papers. [...]
Antibodies Editorial Office
doaj   +2 more sources

Acknowledgement to Reviewers of Antibodies in 2015 [PDF]

Antibodies, 2016
The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2015. [...]
Antibodies Editorial Office
doaj   +2 more sources

Extreme Point Sort Transformation Combined With a Long Short-Term Memory Network Algorithm for the Raman-Based Identification of Therapeutic Monoclonal Antibodies

Frontiers in Chemistry, 2022
Therapeutic monoclonal antibodies (mAbs) are a new generation of protein-based medicines that are usually expensive and thus represent a target for counterfeiters.
Jin Ling, Luxia Zheng, Mingming Xu, Gang Chen, Xiao Wang, Danzhuo Mao, Hong Shao   +6 more
doaj   +1 more source

Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model

Frontiers in Oncology, 2022
DNA-encoded delivery and in vivo expression of antibody therapeutics presents an innovative alternative to conventional protein production and administration, including for cancer treatment.
Kevin Hollevoet, Kevin Hollevoet, Debby Thomas, Debby Thomas, Griet Compernolle, Griet Compernolle, Giles Vermeire, Elien De Smidt, Elien De Smidt, Stéphanie De Vleeschauwer, Trevor R. F. Smith, Paul D. Fisher, Maarten Dewilde, Maarten Dewilde, Nick Geukens, Paul Declerck, Paul Declerck   +16 more
doaj   +1 more source

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies

Nature Communications, 2021
Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions of these different antibody classes to the polyclonal response remains unclear.
Allison J. Greaney, Tyler N. Starr, C. Barnes, Y. Weisblum, F. Schmidt, M. Caskey, C. Gaebler, A. Cho, Marianna Agudelo, Shlomo Finkin, Zijun Wang, D. Poston, Frauke Muecksch, T. Hatziioannou, P. Bieniasz, D. Robbiani, M. Nussenzweig, P. Bjorkman, J. Bloom   +18 more
semanticscholar   +1 more source

Expression cloning and production of Human Heavy Chain Only antibodies from murine transgenic plasma cells

Frontiers in Immunology, 2016
Several technologies have been developed to isolate human antibodies against different target antigens as a source of potential therapeutics, including hybridoma technology, phage and yeast display systems.
Dubravka Drabek, Rick Janssens, Ernie de Boer, Rik Rademaker, Johannes Kloess, John Skehel, Frank Grosveld, Frank Grosveld   +7 more
doaj   +1 more source

Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies

Lancet Neurology, 2008
Summary Background A severe form of encephalitis associated with antibodies against NR1–NR2 heteromers of the NMDA receptor was recently identified. We aimed to analyse the clinical and immunological features of patients with the disorder and examine the
J. Dalmau, A. Gleichman, Ethan G. Hughes, J. E. Rossi, Xiaoyu Peng, Meizan Lai, S. Dessain, M. Rosenfeld, R. Balice-Gordon, D. Lynch   +9 more
semanticscholar   +1 more source

Single-Cell Technologies for the Study of Antibody-Secreting Cells

Frontiers in Immunology, 2022
Antibody-secreting cells (ASC), plasmablasts and plasma cells, are terminally differentiated B cells responsible for large-scale production and secretion of antibodies.
Matteo Broketa, Matteo Broketa, Pierre Bruhns   +2 more
doaj   +1 more source

Antibody Engineering for the Development of Therapeutic Antibodies

Molecules and Cells, 2005
Therapeutic antibodies represent one of the fastest growing areas of the pharmaceutical industry. There are currently 19 monoclonal antibodies in the market that have been approved by the FDA and over 150 in clinical developments. Driven by innovation and technological developments, therapeutic antibodies are the second largest biopharmaceutical ...
Sang Jick, Kim, Youngwoo, Park, Hyo Jeong, Hong   +2 more
openaire   +2 more sources

Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19

New England Journal of Medicine, 2020
Covid-19 Antibodies after Mild Infection Among 34 volunteers who had recovered from mild Covid-19 illness, antiviral antibodies to the receptor-binding domain of the viral spike protein declined wi...
F. J. Ibarrondo, J. Fulcher, David Goodman-Meza, J. Elliott, C. Hofmann, M. Hausner, Kathie G Ferbas, Nicole H. Tobin, G. Aldrovandi, O. Yang   +9 more
semanticscholar   +1 more source